Parkinson's Disease Drug Market Report

China Parkinson's Disease Drug Industry Market Research Report 2023-2029

  • POSTDATE：Sep 08, 2023
  • PAGES：218
  • REPORT CODE：GMM1782759
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Parkinson's Disease Drug industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Abbvie

    • Boehringer Ingelheim

    • Apokyn

    • Astellas Pharma

    • Novartis

    • Valeant

    • Teva Pharmaceutical

    • GSK

    • Stada Arzneimittel

    • Kyowa Hakko Kirin Pharma

    • Orion

    • Endo Pharmaceuticals

    • Merck

    • Valeant Pharmaceuticals

    By Type:

    • Trastal

    • COMT Inhibitor

    • Sinemet-CR

    • Others

    • Madopar

    By Application:

    • 40-65 Years Old

    • Above 65 Years Old

    • Under 40 Years Old

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Parkinson's Disease Drug Market Overview 2018-2029

    • 1.1 China Parkinson's Disease Drug Industry Development Overview

    • 1.2 China Parkinson's Disease Drug Industry Development History

    • 1.3 China Parkinson's Disease Drug Industry Market Size (2018-2029)

    • 1.4 China Parkinson's Disease Drug Market Analysis by Type from Production Side

      • 1.4.1 China Parkinson's Disease Drug Production Volume, Production Value and Growth Rate of Trastal (2018-2029)

      • 1.4.2 China Parkinson's Disease Drug Production Volume, Production Value and Growth Rate of COMT Inhibitor (2018-2029)

      • 1.4.3 China Parkinson's Disease Drug Production Volume, Production Value and Growth Rate of Sinemet-CR (2018-2029)

      • 1.4.4 China Parkinson's Disease Drug Production Volume, Production Value and Growth Rate of Others (2018-2029)

      • 1.4.5 China Parkinson's Disease Drug Production Volume, Production Value and Growth Rate of Madopar (2018-2029)

    • 1.5 China Parkinson's Disease Drug Market Analysis by Application from Consumption End

      • 1.5.1 China Parkinson's Disease Drug Sales Volume, Sales Value and Growth Rate of 40-65 Years Old (2018-2029)

      • 1.5.2 China Parkinson's Disease Drug Sales Volume, Sales Value and Growth Rate of Above 65 Years Old (2018-2029)

      • 1.5.3 China Parkinson's Disease Drug Sales Volume, Sales Value and Growth Rate of Under 40 Years Old (2018-2029)

    • 1.6 China Parkinson's Disease Drug Market Analysis by Region

      • 1.6.1 North China Parkinson's Disease Drug Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Parkinson's Disease Drug Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Parkinson's Disease Drug Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Parkinson's Disease Drug Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Parkinson's Disease Drug Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Parkinson's Disease Drug Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Parkinson's Disease Drug Market Size and Growth Rate from 2018-2029

    Chapter 2 China Parkinson's Disease Drug Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Parkinson's Disease Drug Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Parkinson's Disease Drug Market Status and Competition Analysis in 2023

      • 2.2.3 China Parkinson's Disease Drug Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Parkinson's Disease Drug Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Parkinson's Disease Drug Industry Development

    Chapter 3 Parkinson's Disease DrugIndustry Chain Analysis

    • 3.1 Parkinson's Disease Drug Industry Chain

    • 3.2 Parkinson's Disease Drug Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Parkinson's Disease Drug Market

    • 3.3 Parkinson's Disease Drug Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Parkinson's Disease Drug Market

    Chapter 4 China Parkinson's Disease Drug Market, by Type

    • 4.1 China Parkinson's Disease Drug Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Parkinson's Disease Drug Total Production Volume and Growth Rate from Production Side

    • 4.5 China Parkinson's Disease Drug Production Volume and Growth Rate, by Type

      • 4.5.1 China Parkinson's Disease Drug Production Volume and Growth Rate of Trastal

      • 4.5.2 China Parkinson's Disease Drug Production Volume and Growth Rate of COMT Inhibitor

      • 4.5.3 China Parkinson's Disease Drug Production Volume and Growth Rate of Sinemet-CR

      • 4.5.4 China Parkinson's Disease Drug Production Volume and Growth Rate of Others

      • 4.5.5 China Parkinson's Disease Drug Production Volume and Growth Rate of Madopar

    Chapter 5 China Parkinson's Disease Drug Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Parkinson's Disease Drug Total Market Size and Growth Rate from Consumption End

    • 5.5 China Parkinson's Disease Drug Market Size and Growth Rate, by Application

      • 5.5.1 China Parkinson's Disease Drug Market Size and Growth Rate of 40-65 Years Old

      • 5.5.2 China Parkinson's Disease Drug Market Size and Growth Rate of Above 65 Years Old

      • 5.5.3 China Parkinson's Disease Drug Market Size and Growth Rate of Under 40 Years Old

    Chapter 6 China Parkinson's Disease Drug Market, by Region

    • 6.1 China Parkinson's Disease Drug Production Volume and Production Value, by Region

    • 6.2 China Parkinson's Disease Drug Sales Volume and Sales Value, by Region

    Chapter 7 North China Parkinson's Disease Drug Market Analysis

    • 7.1 North China Parkinson's Disease Drug Market, by Type

    • 7.2 North China Parkinson's Disease Drug Market, by Application

    Chapter 8 Central China Parkinson's Disease Drug Market Analysis

    • 8.1 Central China Parkinson's Disease Drug Market, by Type

    • 8.2 Central China Parkinson's Disease Drug Market, by Application

    Chapter 9 South China Parkinson's Disease Drug Market Analysis

    • 9.1 South China Parkinson's Disease Drug Market, by Type

    • 9.2 South China Parkinson's Disease Drug Market, by Application

    Chapter 10 East China Parkinson's Disease Drug Market Analysis

    • 10.1 East China Parkinson's Disease Drug Market, by Type

    • 10.2 East China Parkinson's Disease Drug Market, by Application

    Chapter 11 Northeast China Parkinson's Disease Drug Market Analysis

    • 11.1 Northeast China Parkinson's Disease Drug Market, by Type

    • 11.2 Northeast China Parkinson's Disease Drug Market, by Application

    Chapter 12 Southwest China Parkinson's Disease Drug Market Analysis

    • 12.1 Southwest China Parkinson's Disease Drug Market, by Type

    • 12.2 Southwest China Parkinson's Disease Drug Market, by Application

    Chapter 13 Northwest China Parkinson's Disease Drug Market Analysis

    • 13.1 Northwest China Parkinson's Disease Drug Market, by Type

    • 13.2 Northwest China Parkinson's Disease Drug Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Abbvie

        • 14.1.1 Abbvie Company Profile

        • 14.1.2 Abbvie Parkinson's Disease Drug Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Boehringer Ingelheim

        • 14.2.1 Boehringer Ingelheim Company Profile

        • 14.2.2 Boehringer Ingelheim Parkinson's Disease Drug Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Apokyn

        • 14.3.1 Apokyn Company Profile

        • 14.3.2 Apokyn Parkinson's Disease Drug Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Astellas Pharma

        • 14.4.1 Astellas Pharma Company Profile

        • 14.4.2 Astellas Pharma Parkinson's Disease Drug Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Novartis

        • 14.5.1 Novartis Company Profile

        • 14.5.2 Novartis Parkinson's Disease Drug Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Valeant

        • 14.6.1 Valeant Company Profile

        • 14.6.2 Valeant Parkinson's Disease Drug Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Teva Pharmaceutical

        • 14.7.1 Teva Pharmaceutical Company Profile

        • 14.7.2 Teva Pharmaceutical Parkinson's Disease Drug Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 GSK

        • 14.8.1 GSK Company Profile

        • 14.8.2 GSK Parkinson's Disease Drug Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 Stada Arzneimittel

        • 14.9.1 Stada Arzneimittel Company Profile

        • 14.9.2 Stada Arzneimittel Parkinson's Disease Drug Market Performance

        • 14.9.3 Product&Service Introduction

      • 14.10 Kyowa Hakko Kirin Pharma

        • 14.10.1 Kyowa Hakko Kirin Pharma Company Profile

        • 14.10.2 Kyowa Hakko Kirin Pharma Parkinson's Disease Drug Market Performance

        • 14.10.3 Product&Service Introduction

      • 14.11 Orion

        • 14.11.1 Orion Company Profile

        • 14.11.2 Orion Parkinson's Disease Drug Market Performance

        • 14.11.3 Product&Service Introduction

      • 14.12 Endo Pharmaceuticals

        • 14.12.1 Endo Pharmaceuticals Company Profile

        • 14.12.2 Endo Pharmaceuticals Parkinson's Disease Drug Market Performance

        • 14.12.3 Product&Service Introduction

      • 14.13 Merck

        • 14.13.1 Merck Company Profile

        • 14.13.2 Merck Parkinson's Disease Drug Market Performance

        • 14.13.3 Product&Service Introduction

      • 14.14 Valeant Pharmaceuticals

        • 14.14.1 Valeant Pharmaceuticals Company Profile

        • 14.14.2 Valeant Pharmaceuticals Parkinson's Disease Drug Market Performance

        • 14.14.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Parkinson's Disease Drug Industry Research Conclusions

    • 15.2 Parkinson's Disease Drug Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Parkinson's Disease Drug Industry Market Size (2018-2029)

    • Figure China Parkinson's Disease Drug Production Volume, Production Value and Growth Rate of Trastal (2018-2029)

    • Figure China Parkinson's Disease Drug Production Volume, Production Value and Growth Rate of COMT Inhibitor (2018-2029)

    • Figure China Parkinson's Disease Drug Production Volume, Production Value and Growth Rate of Sinemet-CR (2018-2029)

    • Figure China Parkinson's Disease Drug Production Volume, Production Value and Growth Rate of Others (2018-2029)

    • Figure China Parkinson's Disease Drug Production Volume, Production Value and Growth Rate of Madopar (2018-2029)

    • Figure China Parkinson's Disease Drug Sales Volume, Sales Value and Growth Rate of 40-65 Years Old (2018-2029)

    • Figure China Parkinson's Disease Drug Sales Volume, Sales Value and Growth Rate of Above 65 Years Old (2018-2029)

    • Figure China Parkinson's Disease Drug Sales Volume, Sales Value and Growth Rate of Under 40 Years Old (2018-2029)

    • Figure North China Parkinson's Disease Drug Market Size and Growth Rate from 2018-2029

    • Figure Central China Parkinson's Disease Drug Market Size and Growth Rate from 2018-2029

    • Figure South China Parkinson's Disease Drug Market Size and Growth Rate from 2018-2029

    • Figure East China Parkinson's Disease Drug Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Parkinson's Disease Drug Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Parkinson's Disease Drug Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Parkinson's Disease Drug Market Size and Growth Rate from 2018-2029

    • Figure Parkinson's Disease Drug Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Parkinson's Disease Drug Market Share by Type in 2018

    • Figure China Parkinson's Disease Drug Market Share by Type in 2023

    • Figure China Parkinson's Disease Drug Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Parkinson's Disease Drug Production Volume and Growth Rate of Trastal (2018-2023)

    • Figure China Parkinson's Disease Drug Production Volume and Growth Rate of COMT Inhibitor (2018-2023)

    • Figure China Parkinson's Disease Drug Production Volume and Growth Rate of Sinemet-CR (2018-2023)

    • Figure China Parkinson's Disease Drug Production Volume and Growth Rate of Others (2018-2023)

    • Figure China Parkinson's Disease Drug Production Volume and Growth Rate of Madopar (2018-2023)

    • Figure China Parkinson's Disease Drug Market Share by Application in 2018

    • Figure China Parkinson's Disease Drug Market Share by Application in 2023

    • Figure China Parkinson's Disease Drug Total Market Size and Growth Rate from Consumption End

    • Figure China Parkinson's Disease Drug Market Size and Growth Rate of 40-65 Years Old (2018-2023)

    • Figure China Parkinson's Disease Drug Market Size and Growth Rate of Above 65 Years Old (2018-2023)

    • Figure China Parkinson's Disease Drug Market Size and Growth Rate of Under 40 Years Old (2018-2023)

    • Table China Parkinson's Disease Drug Production Volume by Region (2018-2023)

    • Table China Parkinson's Disease Drug Production Volume Share by Region (2018-2023)

    • Figure China Parkinson's Disease Drug Production Volume Share by Region (2018-2023)

    • Table China Parkinson's Disease Drug Production Value by Region (2018-2023)

    • Table China Parkinson's Disease Drug Production Value Share by Region (2018-2023)

    • Figure China Parkinson's Disease Drug Production Value Share by Region (2018-2023)

    • Table China Parkinson's Disease Drug Sales Volume by Region (2018-2023)

    • Table China Parkinson's Disease Drug Sales Volume Share by Region (2018-2023)

    • Figure China Parkinson's Disease Drug Sales Volume Share by Region (2018-2023)

    • Table China Parkinson's Disease Drug Sales Value by Region (2018-2023)

    • Table China Parkinson's Disease Drug Sales Value Share by Region (2018-2023)

    • Figure China Parkinson's Disease Drug Sales Value Share by Region (2018-2023)

    • Table North China Parkinson's Disease Drug Production Volume by Type (2018-2023)

    • Table North China Parkinson's Disease Drug Production Volume Share by Type (2018-2023)

    • Figure North China Parkinson's Disease Drug Production Volume Share by Type (2018-2023)

    • Table North China Parkinson's Disease Drug Sales Volume by Application (2018-2023)

    • Table North China Parkinson's Disease Drug Sales Volume Share by Application (2018-2023)

    • Figure North China Parkinson's Disease Drug Sales Volume Share by Application (2018-2023)

    • Table Central China Parkinson's Disease Drug Production Volume by Type (2018-2023)

    • Table Central China Parkinson's Disease Drug Production Volume Share by Type (2018-2023)

    • Figure Central China Parkinson's Disease Drug Production Volume Share by Type (2018-2023)

    • Table Central China Parkinson's Disease Drug Sales Volume by Application (2018-2023)

    • Table Central China Parkinson's Disease Drug Sales Volume Share by Application (2018-2023)

    • Figure Central China Parkinson's Disease Drug Sales Volume Share by Application (2018-2023)

    • Table South China Parkinson's Disease Drug Production Volume by Type (2018-2023)

    • Table South China Parkinson's Disease Drug Production Volume Share by Type (2018-2023)

    • Figure South China Parkinson's Disease Drug Production Volume Share by Type (2018-2023)

    • Table South China Parkinson's Disease Drug Sales Volume by Application (2018-2023)

    • Table South China Parkinson's Disease Drug Sales Volume Share by Application (2018-2023)

    • Figure South China Parkinson's Disease Drug Sales Volume Share by Application (2018-2023)

    • Table East China Parkinson's Disease Drug Production Volume by Type (2018-2023)

    • Table East China Parkinson's Disease Drug Production Volume Share by Type (2018-2023)

    • Figure East China Parkinson's Disease Drug Production Volume Share by Type (2018-2023)

    • Table East China Parkinson's Disease Drug Sales Volume by Application (2018-2023)

    • Table East China Parkinson's Disease Drug Sales Volume Share by Application (2018-2023)

    • Figure East China Parkinson's Disease Drug Sales Volume Share by Application (2018-2023)

    • Table Northeast China Parkinson's Disease Drug Production Volume by Type (2018-2023)

    • Table Northeast China Parkinson's Disease Drug Production Volume Share by Type (2018-2023)

    • Figure Northeast China Parkinson's Disease Drug Production Volume Share by Type (2018-2023)

    • Table Northeast China Parkinson's Disease Drug Sales Volume by Application (2018-2023)

    • Table Northeast China Parkinson's Disease Drug Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Parkinson's Disease Drug Sales Volume Share by Application (2018-2023)

    • Table Southwest China Parkinson's Disease Drug Production Volume by Type (2018-2023)

    • Table Southwest China Parkinson's Disease Drug Production Volume Share by Type (2018-2023)

    • Figure Southwest China Parkinson's Disease Drug Production Volume Share by Type (2018-2023)

    • Table Southwest China Parkinson's Disease Drug Sales Volume by Application (2018-2023)

    • Table Southwest China Parkinson's Disease Drug Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Parkinson's Disease Drug Sales Volume Share by Application (2018-2023)

    • Table Northwest China Parkinson's Disease Drug Production Volume by Type (2018-2023)

    • Table Northwest China Parkinson's Disease Drug Production Volume Share by Type (2018-2023)

    • Figure Northwest China Parkinson's Disease Drug Production Volume Share by Type (2018-2023)

    • Table Northwest China Parkinson's Disease Drug Sales Volume by Application (2018-2023)

    • Table Northwest China Parkinson's Disease Drug Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Parkinson's Disease Drug Sales Volume Share by Application (2018-2023)

    • Table Abbvie Company Profile

    • Table Abbvie Parkinson's Disease Drug Revenue, Price and Gross (2018-2023)

    • Table Boehringer Ingelheim Company Profile

    • Table Boehringer Ingelheim Parkinson's Disease Drug Revenue, Price and Gross (2018-2023)

    • Table Apokyn Company Profile

    • Table Apokyn Parkinson's Disease Drug Revenue, Price and Gross (2018-2023)

    • Table Astellas Pharma Company Profile

    • Table Astellas Pharma Parkinson's Disease Drug Revenue, Price and Gross (2018-2023)

    • Table Novartis Company Profile

    • Table Novartis Parkinson's Disease Drug Revenue, Price and Gross (2018-2023)

    • Table Valeant Company Profile

    • Table Valeant Parkinson's Disease Drug Revenue, Price and Gross (2018-2023)

    • Table Teva Pharmaceutical Company Profile

    • Table Teva Pharmaceutical Parkinson's Disease Drug Revenue, Price and Gross (2018-2023)

    • Table GSK Company Profile

    • Table GSK Parkinson's Disease Drug Revenue, Price and Gross (2018-2023)

    • Table Stada Arzneimittel Company Profile

    • Table Stada Arzneimittel Parkinson's Disease Drug Revenue, Price and Gross (2018-2023)

    • Table Kyowa Hakko Kirin Pharma Company Profile

    • Table Kyowa Hakko Kirin Pharma Parkinson's Disease Drug Revenue, Price and Gross (2018-2023)

    • Table Orion Company Profile

    • Table Orion Parkinson's Disease Drug Revenue, Price and Gross (2018-2023)

    • Table Endo Pharmaceuticals Company Profile

    • Table Endo Pharmaceuticals Parkinson's Disease Drug Revenue, Price and Gross (2018-2023)

    • Table Merck Company Profile

    • Table Merck Parkinson's Disease Drug Revenue, Price and Gross (2018-2023)

    • Table Valeant Pharmaceuticals Company Profile

    • Table Valeant Pharmaceuticals Parkinson's Disease Drug Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US